MarketCap
Facebook
X
TelegramAnnual report 2025
added 11-25-2025
Becton, Dickinson and Company Total Current Liabilities 2011-2026 | BDX
Annual Total Current Liabilities Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.31 B | 8.96 B | 6.64 B | 7.81 B | 6.63 B | 5.84 B | 5.66 B | 7.22 B | 3.34 B | 4.4 B | 4.39 B | 2.24 B | 2.13 B | 1.98 B | 1.82 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.96 B | 1.82 B | 5.16 B |
Total Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
6.51 B | $ 20.07 | -4.72 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | USA |
 |
ICU Medical
ICUI
|
556 M | $ 151.18 | -1.18 % | $ 3.69 B | USA |
 |
InfuSystem Holdings
INFU
|
14.5 M | $ 8.77 | 1.15 % | $ 181 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
4.45 M | $ 5.87 | 3.89 % | $ 268 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
7.54 M | $ 8.45 | 6.56 % | $ 170 M | USA |
 |
AtriCure
ATRC
|
73.4 M | $ 37.21 | -10.25 % | $ 1.75 B | USA |
 |
Masimo Corporation
MASI
|
618 M | $ 130.93 | -5.75 % | $ 6.98 B | USA |
 |
electroCore
ECOR
|
8.12 M | $ 6.35 | 12.79 % | $ 35 K | USA |
 |
Merit Medical Systems
MMSI
|
216 M | $ 83.15 | -3.74 % | $ 4.84 B | USA |
 |
AngioDynamics
ANGO
|
76.2 M | $ 10.16 | 3.04 % | $ 415 M | USA |
 |
The Cooper Companies
COO
|
1.11 B | $ 83.29 | -0.19 % | $ 16.6 B | USA |
 |
LeMaitre Vascular
LMAT
|
30.6 M | $ 84.2 | -0.94 % | $ 1.89 B | USA |
 |
Haemonetics Corporation
HAE
|
578 M | $ 82.57 | 0.66 % | $ 4.16 B | USA |
 |
Harvard Bioscience
HBIO
|
26.5 M | $ 0.62 | -2.13 % | $ 26.3 M | USA |
 |
Glaukos Corporation
GKOS
|
74 M | $ 111.12 | -1.6 % | $ 5.38 B | USA |
 |
Isoray
ISR
|
18.2 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
111 M | $ 168.23 | -6.24 % | $ 5.25 B | USA |
 |
OraSure Technologies
OSUR
|
33.5 M | $ 2.7 | 2.66 % | $ 201 M | USA |
 |
Intuitive Surgical
ISRG
|
1.75 B | $ 572.2 | -2.39 % | $ 203 B | USA |
 |
Microbot Medical
MBOT
|
3.79 M | $ 2.13 | 2.15 % | $ 21.7 M |  Israel |
 |
Nephros
NEPH
|
2.11 M | $ 4.58 | -4.78 % | $ 47.6 M | USA |
 |
Milestone Scientific
MLSS
|
3.74 M | $ 0.29 | -1.09 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
879 M | $ 23.47 | -0.68 % | $ 4.04 B | USA |
 |
Predictive Oncology
POAI
|
3.59 M | $ 6.84 | 0.22 % | $ 37.3 M | USA |
 |
Pro-Dex
PDEX
|
14.6 M | $ 43.19 | 3.46 % | $ 142 M | USA |
 |
Pulse Biosciences
PLSE
|
6.71 M | $ 14.47 | -0.17 % | $ 695 M | USA |
 |
Repligen Corporation
RGEN
|
165 M | $ 169.22 | 1.44 % | $ 9.43 M | USA |
 |
ResMed
RMD
|
689 M | $ 257.08 | 1.8 % | $ 37.6 B | USA |
 |
BioLife Solutions
BLFS
|
32.7 M | $ 24.15 | -2.86 % | $ 1.11 B | USA |
 |
STERIS plc
STE
|
1.02 B | $ 260.03 | 1.31 % | $ 25.6 B | USA |
 |
Stereotaxis
STXS
|
13.2 M | $ 2.56 | 1.79 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
8.78 M | $ 0.76 | -1.91 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
70.3 M | $ 22.06 | -0.26 % | $ 1.08 B | USA |
 |
Teleflex Incorporated
TFX
|
649 M | $ 109.07 | -3.33 % | $ 5.11 B | USA |
 |
Utah Medical Products
UTMD
|
4.71 M | $ 60.1 | 0.33 % | $ 218 M | USA |
 |
West Pharmaceutical Services
WST
|
550 M | $ 272.1 | -1.18 % | $ 19.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.59 B | $ 12.44 | -2.7 % | $ 2.53 B | USA |